Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

BofA Keeps Sell on Oxford Health


Banc of America reiterated its sell rating on Oxford Health (OHP).

Analyst Joseph France says although Oxford appears to be seeking an acquiror, Friday's announcement that WellChoice has terminated merger talks with Oxford corroborated his view that the health-benefits provider wasn't a likely acquisition target for WellChoice. He believes the deal would have been dilutive for WellChoice at prices lower than where Oxford currently trades. WellCoice is the parent of Empire Blue Cross Blue Shield.

France notes his 2004 earnings per share estimates for Oxford are materially below consensus estimates. He believes the company's margins have peaked, and that it will be difficult for it to grow this year. France has a $37 target, which assumes the stock trades at about 9.3 times his 2004 earnings per share estimate, and 8.3 times his 2005 estimate.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus